Home » Topics » BioWorld Science

BioWorld Science
RSS

IMPACT Therapeutics identifies new Wee1 inhibitors

May 7, 2021

DarwinHealth and Bristol Myers Squibb establish Novel Cancer Target Initiative

May 7, 2021

Aucentra Therapeutics patents CDK inhibitors

May 7, 2021

Medshine Discovery divulges new CDK inhibitors

May 7, 2021

Positive 12- and 24-month data reported from ongoing XLRP phase I/II study

May 7, 2021

Intraocular pressure lowering by soluble guanylate cyclase inhibitor ID-65-CW69 studied in monkeys

May 7, 2021

Interim data from RUBY study presented for OKG-0301 in AC

May 7, 2021

Erasca opens enrollment in phase Ib/II study of ERAS-007 in advanced or metastatic solid tumors

May 7, 2021

Phase II trial evaluates Telomelysin, pembrolizumab and stereotactic radiation in head & neck cancer

May 6, 2021

Moderna reports initial COVID-19 vaccine booster data with mRNA-1273 and mRNA-1273.351

May 6, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...